best practice:- Contents

Issue 2 December 2006 - Contents

Welcome to the second issue of the ‘best practice’ jounal
It was encouraging to read the feedback from our first issue of ‘best practice’. This is a learning curve for us but we are pleased to hear we are on the right track. As well as the congratulatory comments we were pleased to get some suggestions for improvements. All comments we get help to shape future issues of ‘best practice’.
Some clinicians tell us they prefer succinct articles, which neatly summarise current thinking with pointers toward further reading, others prefer articles which are more academic in their style and explore the evidence around issues that are subjects of current debate. We hope you will find articles in this issue that suit your preference.
The main themes in this issue are the management of atrial fibrillation and flutter in primary care and the role of long-acting beta agonists (LABA) in asthma management.
We are always pleased to receive your comments and suggestions.
Regards,
The bpac^nz team

Warfarin	Select
Atrial fibrillation and flutter in primary care Choosing between aspirin or warfarin for stroke prevention in AF Rate control is usually preferred to rhythm control to reduce the haemodynamic disturbance of AF Most people with AF can take warfarin safely References
Update on the use of LABAs for the treatment of Asthma	Select
Long acting beta agonists (LABAs) are useful drugs in asthma management however they should only be prescribed for patients who are already on inhaled corticosteroids (ICS). There are safety concerns about their use in acute asthma. Current asthma management plans do not take into account combination LABA/ICS inhalers and patients need clear guidance on what to do in exacerbations.
TCAs are an effective alternative to SSRIs in the treatment of depression	Select
Tricyclic antidepressants (TCAs) are an effective alternative to selective serotonin re-uptake inhibitors (SSRIs) in the treatment of depression and are first-line agents for neuropathic pain. Prescribing points include consideration of adverse effects, drug interactions and withdrawal syndrome.
Essentials	Select
Direct to Consumer Advertising In New Zealand. Is the end in sight? Improving the care of children with asthma NNT - Eases understanding of evidence Patients on amiodarone can fall between the cracks Dear Dave SSRIs and bleeding disorders. Correspondence 10 minute audit Identifying your patients on LABAs.